We serve Chemical Name:N,N’-Dibenzyl-1,3-propanediaMine CAS:372111-26-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:N,N’-Dibenzyl-1,3-propanediaMine
CAS.NO:372111-26-7
Synonyms:N,N’-Dibenzyl-1,3-propanediaMine
Molecular Formula:C17H22N2
Molecular Weight:254.36998
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N,N’-Dibenzyl-1,3-propanediaMine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N’-Dibenzyl-1,3-propanediaMine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,N’-Dibenzyl-1,3-propanediaMine Use and application,N,N’-Dibenzyl-1,3-propanediaMine technical grade,usp/ep/jp grade.
Related News: The first is the API �C which is the central ingredient. N,N’-Dibenzyl-1,3-propanediaMine manufacturer But now, the metropolis of 11 million in Hubei province has become the face of a deadly coronavirus outbreak — a stigma the people of Wuhan increasingly find themselves unable to shake off. N,N’-Dibenzyl-1,3-propanediaMine supplier Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs. N,N’-Dibenzyl-1,3-propanediaMine vendor But now, the metropolis of 11 million in Hubei province has become the face of a deadly coronavirus outbreak — a stigma the people of Wuhan increasingly find themselves unable to shake off. N,N’-Dibenzyl-1,3-propanediaMine factory GlaxoSmithKline��s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.